Melzack R, Ofiesh J G, Mount B M
Can Med Assoc J. 1976 Jul 17;115(2):125-9.
Terminally ill cancer patients were given the Brompton mixture and a phenothiazine in an attempt to control their pain. The mixture was administered to patients in three hospital environments: a palliative care unit (PCU), general wards and private rooms. Pain was measured in 92 patients with the McGill-Melzack Pain Questionnaire. The Brompton mixture controlled pain in 90% of patients in the PCU and in 75% to 80% of patients in the wards or private rooms. The differences in pain scores between the PCU patients and the other groups were significant. The mixture produced substantial decreases in the three major dimensions of pain: sensory, affective and evaluative. Comparison of these results with data obtained in an outpatient pain clinic showed that the Brompton mixture was strikingly more effective than the traditional methods of managing cancer pain.
晚期癌症患者被给予布朗普顿合剂和一种吩噻嗪类药物以控制疼痛。该合剂在三种医院环境中给予患者:姑息治疗病房(PCU)、普通病房和私人病房。使用麦吉尔-梅尔扎克疼痛问卷对92名患者的疼痛进行了测量。布朗普顿合剂在PCU中90%的患者身上控制了疼痛,在病房或私人病房中75%至80%的患者身上也有效果。PCU患者与其他组之间的疼痛评分差异显著。该合剂在疼痛的三个主要维度上产生了大幅下降:感觉、情感和评估。将这些结果与在门诊疼痛诊所获得的数据进行比较表明,布朗普顿合剂比传统的癌症疼痛管理方法显著更有效。